{"id":15982,"date":"2017-02-23T19:59:41","date_gmt":"2017-02-23T19:59:41","guid":{"rendered":"https:\/\/blogbox.indianeagle.com\/?p=15982"},"modified":"2017-02-23T20:23:16","modified_gmt":"2017-02-23T20:23:16","slug":"lawyer-birender-sangwan-fights-against-overpricing-of-coronary-stents","status":"publish","type":"post","link":"https:\/\/www.indianeagle.com\/travelbeats\/lawyer-birender-sangwan-fights-against-overpricing-of-coronary-stents\/","title":{"rendered":"This Indian Lawyer Gifts Hearts to Millions of People Affected by Cardiovascular Diseases"},"content":{"rendered":"
37-year-old lawyer Birender Sangwan is at the helm of a major recent change in India\u2019s $100 billion healthcare industry for the sake of millions of people who couldn\u2019t afford cardiovascular surgery due to exorbitantly high prices of coronary stent,<\/strong> a metal or plastic tube inserted into the body through a small puncture in a leg or arm to open up blocked arteries and restore normal blood flow to the heart. India\u2019s $531 million coronary stent industry used to inflate through rampant profiteering by selling stents at unchecked prices with margins up to 654% before lawyer Birender Sangwan initiated a crusade against it.<\/p>\n All thanks to lawyer Birender Sangwan for having moved the government of India to crack the whip on private hospitals which charged cardiovascular patients over INR 1 lakh for a single stent!<\/strong> The National Pharmaceutical Pricing Authority of India cut the price of stent by nearly 85% and capped it at INR 30,000. Furthermore, coronary stent has been included in the National List of Essential Medicines.<\/p>\n This groundbreaking reform was more than a necessity in the healthcare industry of the world\u2019s 7th<\/sup> largest and Asia\u2019s 3rd<\/sup> largest economy where 30 million people are affected by cardiovascular ailments and over 2 million people die of heart attacks as well as strokes every year.<\/p>\n<\/blockquote>\n Source: ScoopWhoop<\/p><\/div>\n In 2015, lawyer Birender Sangwan from Haryana filed a public interest litigation (PIL) in the High Court of Delhi<\/a><\/span>, seeking the government\u2019s intervention in the coronary stent industry which was thriving by overcharging common people for a life-saving device.<\/strong> But, he set out on this mission earlier than the litigation was filed when a private hospital charged his friend INR 126,000 for a coronary stent to save the life of his friend\u2019s brother in 2014. On seeing no maximum retail price of the device on its box, Birender asked the hospital for the purchase bill; but it was refused.<\/p>\n On digging deeper into the market, Birender Sangwan came to know to his surprise that stents were priced at high margins from distribution to supply due to lack of governmental regulation, and that this life-saving device was not on the National List of Essential Medicines. It led him to launch the crusade which was obviously not a roller-coaster ride.<\/p>\n<\/blockquote>\n\n
<\/a>
\n